Dark Day At Idera As Tilsotolimod Fails To ILLUMINATE In Melanoma Study

Prospects Look Bleak

 
• By Kevin Grogan
  
gloomy
Path ahead looks gloomy for tilsotolimod • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D